Nalls Sherbakoff Group’s Zimmer Biomet ZBH Stock Holding History

Nalls Sherbakoff Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30	Closed	-$2.69K	–	421
2026 Q1	$2.69K	Hold	30	–	–	﹤0.01%	365
2025 Q4	$2.68K	Buy	30 +26	+650%	+$2.46K	﹤0.01%	396
2025 Q3	$394	Hold	4	–	–	﹤0.01%	413
2025 Q2	$365	Hold	4	–	–	﹤0.01%	415
2025 Q1	$453	Buy	+4	New	+$428	﹤0.01%	419
2023 Q4	$487	Hold	4	–	–	﹤0.01%	417
2023 Q3	$449	Hold	4	–	–	﹤0.01%	433
2023 Q2	$510	Hold	4	–	–	﹤0.01%	447
2023 Q1	$508	Buy	+4	New	+$502	﹤0.01%	484

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Nalls Sherbakoff Group's ZBH Position: Q2 2026 in Review

Nalls Sherbakoff Group sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 30 shares — an estimated $2.69K sold.

Nalls Sherbakoff Group first reported a position in ZBH in Q1 2023 and held it in 9 quarters. The position peaked at $2.69K in Q1 2026. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Nalls Sherbakoff Group reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
Nalls Sherbakoff Group sold 30 Zimmer Biomet shares in Q2 2026, an estimated $2.69K.
Nalls Sherbakoff Group first reported a position in Zimmer Biomet in Q1 2023 and held it in 9 quarters.
Nalls Sherbakoff Group's Zimmer Biomet position peaked at $2.69K in Q1 2026.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2026, filed 17 Aug 2026.